◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

MEDICAL INNOVATION HOLDINGS, INC.

CIK: 1093248 SIC: 3730
-
Revenue
$-1.44M
Net Income
-
Gross Margin
-
Op. Margin
$-676.52K
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 6 of 17 quarterly reports available
Breakdown Q3 2018
(Jan 31, 2018)
Q2 2018
(Oct 31, 2017)
Q1 2018
(Jul 31, 2017)
Q4 2017
(Apr 30, 2017)
Q3 2017
(Jan 31, 2017)
Q2 2017
(Oct 31, 2016)
+ Total Revenue - $48.00K - - - -
Revenue Growth % (YoY) nan% nan% nan% nan% nan% nan%
Operating Expenses $285.64K $230.65K - - - -
+ Operating Income - - - $1.46M $-314.06K $-57.20K
Operating Margin % nan% nan% nan% nan% nan% nan%
Interest Expense - - - - - -
Other Income/Expense $-213.32K $-74.40K $170.78K - - -
+ Net Income $-498.96K $-305.06K $-349.98K $-282.92K $-314.06K $-57.20K
Net Margin % nan% -635.5% nan% nan% nan% nan%
Basic EPS nan nan nan -0.04 0.01 nan
Diluted EPS nan nan nan -0.04 0.01 nan
Basic Shares Outstanding - - - 373K 38.6M 38.2M
Diluted Shares Outstanding - - - 373K 38.6M 38.2M
Breakdown Q3 2018
(Jan 31, 2018)
Q2 2018
(Oct 31, 2017)
Q1 2018
(Jul 31, 2017)
Q4 2017
(Apr 30, 2017)
Q3 2017
(Jan 31, 2017)
Q2 2017
(Oct 31, 2016)
Cash & Cash Equivalents $6.46K $95.06K $30.69K $8.89K $33.86K $15.78K
Total Current Assets $6.46K $95.06K $30.69K $8.89K $33.86K $15.78K
Total Assets $6.46K $95.06K $30.69K $8.89K $33.86K $15.78K
Accounts Payable $282.57K - - - - -
Short-term Debt - - - - - -
Accrued Liabilities $582.65K - - - - -
Total Current Liabilities - - - $1.13M $869.10K $739.53K
Total Liabilities $1.57M $1.61M $1.35M - - -
Common Stock $3.99K $3.92K $3.92K $3.92K $3.88K $3.84K
Retained Earnings $-2.66M $-2.11M $-1.91M $-1.56M $-1.28M $-965.96K
Total Stockholders Equity $-1.56M $-1.51M $-1.32M $-1.12M $-835.24K $-723.75K
Total Liabilities & Equity $6.46K $95.06K $30.69K $8.89K $33.86K $15.78K
Breakdown Q3 2018
(Jan 31, 2018)
Q2 2018
(Oct 31, 2017)
Q1 2018
(Jul 31, 2017)
Q4 2017
(Apr 30, 2017)
Q3 2017
(Jan 31, 2017)
Q2 2017
(Oct 31, 2016)
Net Income $-498.96K $-592.50K $-349.98K $-282.92K $-314.06K $-303.88K
Change in Payables $111.05K - $126.00K - - -
Operating Cash Flow $-363.43K $-188.84K $-53.20K $-71.05K $-245.11K $-228.02K
Stock Issued $161.00K - - - $295.46K $242.20K
Financing Cash Flow $361.00K $275.00K $75.00K $46.09K $277.36K $242.20K
Net Change in Cash $-2.43K $86.16K $21.80K $-24.96K $32.26K $14.18K
SEC Filing Format - Data shown as it appears in the Q3 2018 (10-Q) filing Period ended: Jan 31, 2018
Condensed Consolidated Statements of Operations
Description Jan 31, 2018 Jan 31, 2018
Current Prior Year Current YTD Prior Year YTD
Total Revenue - - $48.00K -
Operating Expenses $285.64K $314.06K $647.50K $617.94K
Interest Expense - - - -
Other Income/Expense $-213.32K - $-495.43K -
Net Income $-498.96K $-314.06K $-1.14M $-617.94K
Condensed Consolidated Balance Sheets
Description Jan 31, 2018 Apr 30, 2017
Cash & Cash Equivalents $6.46K $8.89K
Total Current Assets $6.46K $8.89K
Total Assets $6.46K $8.89K
Accounts Payable $282.57K $349.70K
Accrued Liabilities $582.65K $455.15K
Total Liabilities $1.57M $1.13M
Common Stock $3.99K $3.92K
Retained Earnings $-2.66M $-1.56M
Total Stockholders Equity $-1.56M $-1.12M
Total Liabilities & Equity $6.46K $8.89K
Condensed Consolidated Statements of Cash Flows
Description Jan 31, 2018 Jan 31, 2018
Current Prior Year Current YTD Prior Year YTD
Net Income $-498.96K $-314.06K $-1.14M $-617.94K
Change in Payables - - $111.05K $-165.81K
Operating Cash Flow - - $-363.43K $-245.11K
Stock Issued - - $161.00K $295.46K
Financing Cash Flow - - $361.00K $277.36K
Net Change in Cash - - $-2.43K $32.26K

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...